Abstract: Idiopathic epilepsies are genetically determined diseases of the central nervous system characterized by typical epileptic seizures and EEG abnormalities but not associated with structural brain lesions. In recent years, an increasing number of mutations associated with idiopathic epilepsy syndromes were identified in genes encoding subunits of voltageor ligand-gated ion channels. These encouraging results provide a plausible pathophysiological concept, since ion channels form the basis for neuronal excitability and are the major targets for anticonvulsive pharmacotherapy. The first epilepsy genes were identified for rare autosomal dominant syndromes within large pedigrees. Recently, a few mutations were also found for the frequent classical forms of idiopathic generalized epilepsies (IGE), for example absence or juvenile myoclonic epilepsy. The mutations can affect ion channels which on one hand have been known since several decades to be crucial for neuronal function, such as the voltage-gated sodium channel or the GABA A receptor, or on the other hand were newly identified within the last decade as KCNQ potassium channels or the ClC-2 chloride channel. Functional studies characterizing the molecular defects of the mutant channels point to a central role of GABAergic synaptic inhibition in the pathophysiology of IGE. Furthermore, newly discovered genes may be suitable as novel targets for pharmacotherapy such as KCNQ channels for the anticonvulsant drug retigabine. Altogether, these genetic and pathophysiological investigations will enhance our knowledge about the understanding of epileptogenesis and can help to improve anticonvulsive therapy.
INTRODUCTION
Epilepsy is one of the most common neurological disorders affecting up to 3% of the world's population during lifetime [1] . The disease is characterized by recurring unprovoked epileptic seizures resulting from synchronized electrical discharges of neurons within the central nervous system (CNS). With regard to the complicated nature and the many different functions of the brain, the number of clinically differentiable seizures types is large. The symptoms of a seizure, the so-called seizure semiology, depends for example on age, the underlying cause and the brain region involved. Accordingly, epileptic semiology can include only mild feelings of the patient himself that are not visible for other individuals (such as seen with an epigastric aura), but also short-lasting black outs (such as known for absence or complex-partial seizures), or severe generalized tonic-clonic convulsions. The most important features used to classify epileptic seizures and epileptic syndromes are (i) the origin of the seizure/epilepsy which can be focal or generalized and (ii) the underlying cause which can be symptomatic (for example due to cortical malformations, brain tumors or stroke) or idiopathic, i.e. genetic [2, 3] .
Idiopathic epilepsy syndromes are characterized by typical seizures, such as absences or myoclonic seizures, and distinct abnormalities of the electroencephalogram (EEG), such as 3-4 Hz generalized spike and wave discharges or generalized polyspikes. These patients usually have a normal *Address correspondence to this author at the Depts. of Applied Physiology and Neurology, University of Ulm, Zentrum Klinische Forschung, Helmholtzstr. 8/1, D-89081 Ulm; Tel: +49-731-5003-3616; Fax: +49-731-5003-3609; E-mail: holger.lerche@medizin.uni-ulm.de magnetic resonance imaging of the brain without an epileptogenic lesion. Within the recent 10 years, the first genes have been identified causing mostly rare monogenic idiopathic epilepsy syndromes, such as autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) or benign familial neonatal convulsions (BFNC). Very recently, mutations were also identified in a few families with the most common idiopathic generalized epilepsies (IGE), which are childhood and juvenile absence epilepsy (CAE, JAE), juvenile myoclonic epilepsy (JME) and epilepsy with Grand-Mal seizures on awakening (EGMA). Almost all of the genes identified so far encode ion channels. This is very well understandable from a pathophysiological point of view, as ion channels provide the basis for both the electrophysiological excitability of neuronal cell membranes and the communication between neurons: Axonal conduction is mediated by voltage-gated channels generating the action potential and signal transduction from cell to cell by ligand-gated channels mediating synaptic transmission. Therefore, any mutation-induced channel malfunction may alter brain excitability and induce epileptic seizures. Underlining this important role of ion channels in epileptology, most anticonvulsant drugs that are in clinical use today modulate different types of ion channels. Best known examples are the use-dependent block of voltage-gated sodium channels by phenytoine, carbamazepine or lamotrigine and the enhancement of GABAergic synaptic inhibition by benzodiazepines, barbiturates, tiagabine or vigabatrine. This review summarizes epileptic syndromes which are associated with mutations in ion channels with regard to their clinical presentation, genetic findings, and functional studies, which have been performed to prove the pathogenicity of mutations and elucidate the molecular pathophysiology. All other idiopathic epilepsy syndromes will not be discussed in this review. Table 1 gives an overview about all syndromes for which linkage to a specific chromosomal region alone or also the responsible genes have been identified. Other recent reviews on this topic are given by [4] [5] [6] . As probably not all of the potential readers are sufficiently familiar with ion channels, the review will start with an overview about the most important structural and functional features of these proteins. Juvenile myoclonic epilepsy JME JME/EJM1 5q34-35 [90] 6p21 [145] [146] [147] GABRA1 [90] - 20q13 [20] 1q21 [22, 23] 15q24 [157] CHRNA4 [21, 27, 30, [154] [155] [156] CHRNB2 [22, 23] Autosomal dominant lateral temporal lobe epilepsy ADLTE 10q23-26 [158] LGI1 [159] Familial partial epilepsy with variable foci FPEVF 22q11-12 [160] -
STRUCTURE AND FUNCTION OF ION CHANNELS
Ion channels are transmembrane proteins allowing the passive flow of Na + , K + , Cl -or Ca 2+ ions along their concentration gradient. They are controlled either by voltage and contribute to action potentials or by ligands -as specific neurotransmitters -and contribute to synaptic transmission. Distinct and structurally conserved classes of ion channels emerged during evolution to mediate these and other processes of excitability. Most important and best studied are the groups of voltage-gated cation channels and of ligandgated channels [7] , which will be explained in more detail below.
Voltage-Gated Cation Channels
Voltage-gated cation channels have pores that are selective for K + , Na + or Ca 2+ ions. Their main α-subunit constitutes structures for gating and permeation while the accessory subunits called β, γ, or δ have only modifying effects. The α-subunits have a tetrameric structure consisting of four homologous domains (I-IV) each with six transmembrane segments (S1-S6). In Na + -and Ca 2+ -channel α-subunits, the entire subunit is encoded by one gene so that the domain arrangements are always the same. In contrast, K + channel genes encode only one domain and by coassembly with domains encoded by other K + channel genes, the tetramers can be of high diversity. Of special importance for the voltage-gated cation channels are the voltage sensitive structures, the S4 segments of all domains. These are located around the ion-selective pore-forming structures constituted by S5-S6 loops (Figs. 3, 4) .
There are three main conformational states of voltagegated channels, a closed resting state, an open conducting state, and a closed inactivated state. At the resting potential, the channels are in the resting state. Upon membrane depolarization, the voltage sensors move outward opening the 'activation gate' of the channel on a time scale of milliseconds. Sustained depolarization leads to channel closing by spontaneous inactivation. The channels cannot be directly activated again from this state, i.e. they are refractory. The inactivation gate is therefore different from the activation gate. Upon membrane repolarization, inactivated channels recover from inactivation ( Fig. 1) . Variations of kinetics, voltage dependence of channel gating, or the amount of functional protein in the membrane are typical modifying properties of the smaller β-, γ-or δ-subunits [8] [9] [10] .
In an action potential, the steep depolarizing phase is mediated by activation of the Na + inward current, whereas membrane repolarization is due to both fast inactivation of Na + channels and activation of the outward K + current. Consequently, disruption of fast Na + channel inactivation or a decrease in K + conductance can lead to slowed or incomplete repolarization of the cell membrane resulting in Fig. (1) . The three main conformational states of voltage-gated cation channels. From a closed resting state at a hyperpolarized membrane potential, channels open upon depolarization conveyed by outward movement of the voltage sensors opening the activation gate. With ongoing depolarization, some channels, such as the voltage-gated Na + channel, inactivate by binding of the inactivation gate to its receptor site which is exposed when the voltage sensors move outward. From the inactivated state, they can only recover upon repolarization of the cell membrane before they are available for another opening.
hyperexcitability and spontaneous series of action potentials. Main functions of neuronal voltage-gated Ca 2+ channels are the regulation of transmitter release in presynaptic nerve terminals.
There are several genes encoding different Na + channel α-subunits (SCN1A-SCN12A) that show tissue-specific expression patterns: SCN4A is expressed in skeletal muscle and SCN5A in heart muscle. Four of these subunits (SCN1A, SCN2A, SCN3A and SCN8A) are highly expressed in brain [11] . This tissue specificity explains the restricition of symptoms of Na + channel mutations to certain tissue types, for example SCN1A mutations generate febrile and afebrile seizures but not cardiac conduction defects. Voltage-gated K + channels, show less homology to one another than Na + channels and are therefore grouped into several families according to their gating properties. For example there are inactivating (e.g. KCNA1) and non-inactivating (e.g. KCNQ1-5) K + channels both of which are relevant to neuronal excitability (reviewed in [10, 12] ).
Ligand-Gated Ion Channels
Ligand-gated channels are activated by neurotransmitters such as acetylcholine (ACh), γ-amino butyric acid (GABA), glycine, glutamate or nucleotides. Classically, these channels are tetrameric or pentameric associations of subunits of equivalent structure. The subunits all have either two or four transmembrane segments named M1-M4 whereby the ionconducting pore is formed by the M2 segments (Figs. 2, 5 ). The pore is not selective for a specific ion type but may be permeable either to cations, as in excitatory ACh or glutamate receptors, or to anions, such as in inhibitory GABA or glycine receptors. Neurotransmitter affinitiy is dependent on amino acid sequences in many different regions of the channel. There are three main conformational states of these ligand-gated channels: resting, open, and desensitized. Activation occurs by binding of the transmitter, and desensitization (refractoriness) is brought about by prolonged exposure to the neurotransmitter. Removal of the transmitter leads to recovery from desensitization [13] .
Of special relevance to the context of epilepsy are the nicotinic ACh receptors (nAChR) which have a pentameric structure of two α-and three β-subunits (Fig. 2) . In brain, altogether eight α-(α 2-9 ) and three β-(β 2-4 ) subunit isoforms are known to be expressed. The α 4 -and β 2 -subunits encoded by CHRNA4 and CHRNB2, are especially abundant, so it is not surprising that mutations therein cause disease, i.e. autosomal dominant nocturnal frontal lobe epilepsy [14] . Pentameric GABA receptors are also involved in causing epilepsy. There are several different subunits of GABA A receptors (α 1-6 , β 1-3 , γ 1-3 , δ, ε, π, ρ 1-3 ). The subunit composition most abundantly found in brain is probably 2α 1 2β 2 1γ 2 [15, 16] .
Fig. (2).
Proposed structure of the nicotinic acetylcholine receptor with mutations found in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) (references in Table 1 ). Each of the 5 subunits contains 4 transmembrane regions (M1-M4), the M2 segments constitute the ion pore and the long extracellular N-terminal part of the α-subunit contains the binding site for acetylcholine.
AUTOSOMAL DOMINANT NOCTURNAL FRONTAL LOBE EPILEPSY (ADNFLE)
Clinical Picture ADNFLE has an autosomal dominant mode of transmission and a penetrance of 70-80% [17, 18] . The onset is during childhood. The disorder is characterized by brief partial seizures typically occurring during the night and showing hyperkinetic or tonic manifestations. Ictal videoelectroencephalographic studies have revealed that the seizures originate from the frontal lobe. ADNFLE has been often misdiagnosed as paroxysmal nocturnal dyskinesia, or other sleep disorders such as night terrors, nightmares, or hysteria [19] .
Genetics
The first linkage study performed in a large Australian family was suggestive of a locus on chromosome 20q13.2 [20] . Later, a mutation was identified in the CHRNA4 gene encoding the α 4 -subunit of a neuronal nicotinic acetylcholine receptor (nAChR), representing the first ion channel mutation in an inherited form of epilepsy [21] . In the mean time, altogether five CHRNA4 mutations and two mutations in CHRNB2 encoding the homologous β 2 -subunit of neuronal nAChR [22, 23] have been identified. All known mutations are located in the pore-forming M2 transmembrane segments (Fig. 2 , Table 1 ).
Pathophysiology
Functional expression of most of the known mutations in Xenopus oocytes or human embryonic kidney (HEK) cells revealed different effects on gating of heteromeric α 4 β 2 channels leading either to a gain-of-function or a loss-offunction. The pathomechanism is still not clear up to now. A decrease of the overall channel activity by enhanced desensitization, slowed recovery from desensitization, reduced single channel conductance and reduced permeability for Ca 2+ ions was described for the S248F and the 776ins3 mutations in the α 4 -subunit [24] [25] [26] . However, further studies of the same mutations also revealed a usedependent potentiation to repetitive ACh-expositions or a 10-fold increase in ACh-sensitivity that increase channel activity [26] [27] [28] . First studies of the mutations in the β 2 -subunit revealed gain-of-function mechanisms. The V287L mutation showed a profound slowing of desensitization kinetics [22] and V287M showed a 10-fold increase in AChsensitivity [23] . Recently, an increased sensitivity to ACh was found to be a molecular mechanism common for six mutations in α 4 -or β 2 -subunits and therefore postulated as the disease-causing one [29, 30] . In contrast, another investigation of five mutations proposed a reduction of the Ca 2+ sensitivity of the ACh response, thus a loss-of-function, as a common pathomechanism [31] .
Transgenic mice generated with either a knock-out or knock-in of the α 4 -subunit were not reported to develop seizures [32, 33] . However, the knock-in mice showed a decreased threshold for ACh-induced seizures [34] , fitting well with the hypothesis of an increased ACh-sensitivity of the mutations. Thus, a gain-of-function of the nAChR might be the relevant pathomechanism for ADNFLE. How these changes can induce nocturnal frontal lobe seizures remains to be elucidated. Thalamic neurons under cholinergic control, which are part of thalamocortical loops playing a crucial role for rhythmic activities during sleep and also including predominantly the frontal lobe, could be responsible for the pathophysiology of this disease [14] .
BENIGN FAMILIAL NEONATAL CONVULSIONS (BFNC)
Clinical Picture BFNC is a rare dominantly inherited epileptic syndrome with a penetrance of 85% [35, 36] . The seizures manifest within the first weeks of life and typically disappear spontaneously after weeks to months. The neurological examination, interictal EEG and development of these children are often normal. The prognosis is benign with a low risk of about 15% of recurring seizures later in life.
Genetics
Two loci on chromosome 20 [37] and chromosome 8 have been described [38] . In both regions, genes encoding voltage-gated potassium channels of the KCNQ family are located. Two groups independently discovered the first mutations in KCNQ2 (20q13.3 [39, 40] ) and KCNQ3 (8q24 [41] ). All mutations known up to date are summarized in Fig. 3 .
Pathophysiology
The KCNQ gene family encodes delayed rectifier K + channels that are mainly expressed in heart muscle (KCNQ1), in the central nervous system (KCNQ2-5), the inner ear (KCNQ4) and skeletal muscle (KCNQ5) (reviewed by [42] ). They are slowly activated upon long-lasting membrane depolarizations, for example with trains of action potentials, and control the membrane potential near the threshold for the action potential. In this way, KCNQ channels can regulate the frequency of neuronal firing and play a role in repolarization during the late phase of the cardiac action potential. Mutations in four of the five genes identified cause inherited diseases. KCNQ1 mutations cause cardiac arrhythmia in the long QT syndrome [43] , KCNQ2 and KCNQ3 mutations epileptic seizures in BFNC (see above) and KCNQ4 mutations congenital deafness [44] . Functional expression of the known mutations revealed a consistent reduction of the resulting potassium current in KCNQ1-4 [39, [44] [45] [46] [47] [48] [49] (Fig. 4) . This can lead to a membrane depolarization in the subthreshold range in neurons or to an impaired membrane repolarization in cardiac myocytes explaining the occurrence of hyperexcitability in the affected tissues.
However, the effects of the mutations on current reduction were greatly dependent on channel type. Whereas KCNQ1 and KCNQ4 mutations exhibited strong dominant negative effects on WT channels [44] [45] [46] , KCNQ2 and KCNQ3 mutations usually did not but instead produced the disease by a haploinsufficiency mechanism [39, [47] [48] [49] . There is only one report with suggestive evidence of a dominant negative effect of a KCNQ2 mutation on the coexpressed wildtype [49] . Table 1 ). The channels are built of six transmembrane segments (S1-S6). The voltage sensors are constituted by the S4 segments containing positively charged residues, and the ion conducting pore by S5 and S6 segments and the connecting P-loop. The long carboxy (C)-terminus contains an interaction domain enabling KCNQ2 and KCNQ3 channels to form heterotetramers as indicated in the inset (lower right). $: splice site mutation; +: insertion; -: deletion; bp: base pairs. (B) Functional consequences of a BFNC-causing mutation when expressed in Xenopus oocytes. The mutation 2513delG is a single base pair deletion located at amino acid (aa) position 838 (A), just 7 aa before the regular stop codon. It induces a frame shift, change of the last 7 aa and prolongation by another 56 aa before the new stop codon. This mutation largely reduces the resulting potassium current by 20-fold as seen in the raw current traces in (A) and for the average of many such experiments in (B). Coexpression of both wild type (WT) and mutant channels did not result in significantly less than 50% of WT current, suggesting that there was no dominant negative effect of the mutation (modified after [48] ).
It has been shown that KCNQ2 and KCNQ3 channels interact with each other [50] and constitute the so-called 'Mcurrent', a neuronal K + current known since several decades to play an important role in the regulation of the firing rate of neurons [51] . In Xenopus oocytes, coexpression of WT and mutant KCNQ2 with WT KCNQ3 channels in a 1:1:2 ratio resulted in a current reduction of only 20-25% compared to co-expression of both wildtypes in equimolar ratios [47] . Therefore, relatively small changes of the M-current are sufficient to cause epileptic seizures in the neonatal period.
Disease-causing mutations in KCNQ channels are clustered in the pore region and in the C-terminus (Fig. 3A) . Mutations in the pore reduce the K + current by affecting ion conductance, whereas mutations in the C-terminus affect assembly of α-subunits to heteromeric channels. First evidence suggestive for the co-assembly region was given by a C-terminal KCNQ1 mutation causing the Jervell and Lange-Nielson syndrome which disrupted assembly of KCNQ1 channels [52] . Later experiments using chimeras between KCNQ1, KCNQ2 and KCNQ3 channels confirm that the co-assembly region is located in the C-terminus [53, 54] . Presumably, correct tetramerization is necessary for insertion of the channel complex into the outer cell membrane. This would explain the reduced surface expression of a KCNQ2 mutant truncating the C-terminus. In contrast, pore mutations in KCNQ2 and KCNQ3 do not seem to additionally affect surface expression [55] .
The question remains as to why the reduced KCNQ2/ KCNQ3 K + current results in seizures preferentially during the neonatal period. An explanation might be the differential expression of potassium channels during maturation. On one hand, upregulation of these channels during development could gradually lead to a critical amount of KCNQ channels needed for adequate control of the subthreshold membrane potential. A small reduction of the potassium current by mutations may then be sufficient to cause seizures in the neonatal period, when the potassium current is still on a low level, but not in the adult period, when KCNQ channels are abundantly available. Alternatively, upregulation of other potassium channels might help to compensate for the deficit later on. Expression of a shorter, non-functional splice variant of KCNQ2 exclusively in fetal brain, which attenuates KCNQ2 and KCNQ3 channels upon coexpression [56] , could be another reason for the age-dependent phenotype.
BENIGN FAMILIAL INFANTILE CONVULSIONS (BFIC) AND BENIGN FAMILIAL NEONATAL/ INFANTILE CONVULSIONS (BFNIC)
A well established epilepsy syndrome very similar to BFNC is benign familial infantile convulsions (BFIC) [57, 58] , in which partial epileptic seizures with or without secondary generalization develop in clusters between 3 and 12 months of age. The syndrome is also inherited as an autosomal dominant trait, affected individuals develop normally, and adults usually do not develop seizures. The syndrome can be associated with other inherited disorders of the central nervous system, as paroxysmal dyskinesia or migraine. Several different loci were described but a responsible gene has not been identified so far ( Table 1) . Scheffer and colleagues then described two families in which seizures occurred in the first weeks of life, just in between the typical age of manifestation of BFNC and BFIC. They named this syndrome BFNIC (or BFNIS for BFNI seizures). In both families they identified mutations in the gene SCN2A encoding one of the α-subunits of voltage-gated sodium channels expressed in mammalian brain [59] (Fig.  4A) . The mutations have not been functionally examined so far.
Generalized epilepsy with febrile seizures plus (GEFS + ), severe myoclonic epilepsy of infancy (SMEI, Dravet syndrome) and intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC)
Clinical Picture

GEFS
+ was first described in 1997 and 1999 [60, 61] . It is an autosomal dominant childhood-onset syndrome featuring febrile convulsions and a variety of afebrile epileptic seizure types within the same pedigree. Two thirds of affected individuals were diagnosed as febrile convulsion syndrome (FS), often combined with febrile seizures persisting after the 6 th year of life or in combination with afebrile generalized tonic-clonic seizures (called 'FS + '). Other phenotypes characterized by additional seizure semiologies as 'FS + with absences', 'FS + with myoclonic seizures', 'FS + with atonic seizures' or myoclonic astatic epilepsy (MAE) were described in one third of the patients. Partial epilepsies occurred in rare cases ('FS + with temporal lobe epilepsy'). The penetrance was about 60%.
Severe myoclonic epilepsy of infancy, as first described by Dravet [62] , is characterized by clonic and tonic-clonic seizures in the first year of life that are often prolonged and associated with fever. In the cause of the disease, patients develop afebrile generalized myoclonic, absence or tonicclonic seizures, but also simple and complex partial seizures do occur. Developmental stagnation with dementia occurs in early childhood. In contrast to GEFS + , the syndrome is usually resistant to pharmacotherapy. SMEI patients sometimes have a family history of febrile or afebrile seizures and there are families in which GEFS + and SMEI overlap, so that SMEI can be regarded as the most severe phenotype of the GEFS + spectrum [63, 64] .
A similar severe epilepsy syndrome of childhood is intractable childhood epilepsy with generalized tonic clonic seizures (ICEGTC) [65] . Onset and clinical course including mental retardation are as in SMEI, but myoclonic seizures do not occur. Cases of ICEGTC with other family members affected by GEFS + were described [66] . Thus, as also outlined below with regard to the genetic results, the GEFS + spectrum extends from simple febrile seizures to the variety of severe epilepsy syndromes of childhood as ICEGTC, MAE and SMEI.
Sodium Channel Defects in GEFS + , SMEI and ICEGTC
The first genetic defect in this group of diseases was discovered in a large GEFS + pedigree by [67] . The authors described linkage to chr 19q13 and identified a point mutation within the gene SCN1B encoding the β 1 -subunit of the voltage-gated Na + channel. The mutation (C121W, Fig. 4A) (A) (B) Fig. (4) . Proposed structure of the voltage-gated Na + channel α-and β 1 -subunits encoded by the SCN1A, SCN2A (α) and SCN1B genes. The mutations cause GEFS + or BFNIC (A), or SMEI or ICEGTC (B) (references in Table 1 ). Na + channels are built similar to K + channels like shown in Fig. 3A . They have 4 highly homologous repeats (I-IV) with 6 transmembrane segments each (S1-S6) forming a central pore (lower right in A). disrupts a disulfide bridge changing the secondary structure of the β 1 -subunit extracellular loop and leading to a loss of β-subunit function [67, 68] .
Subsequently, several groups found linkage to a cluster of genes encoding neuronal Na + channel α-subunits on chromosome 2q21-33 (Table 1 ) and the first two point mutations were detected in SCN1A predicting amino acid changes within the voltage sensors (S4 segments) of domains II and IV [69] (Fig. 4A) . Many more SCN1A mutations have been described since then in GEFS + families (Fig. 4A) and there is evidence for further genetic as well as clinical heterogeneity [70, 71] , beside the mutations in the GABA A receptor mentioned below.
A few of these mutations have been expressed in human embryonic kidney cells or Xenopus oocytes revealing both gain-and loss-of-function mechanisms. Gain-of-function alterations so far described were an acceleration of recovery from inactivation shortening the refractory period after an action potential (R1648H) [72, 73] , increased persistent sodium currents predicting membrane depolarization (T875M, W1204R, R1648H) [74] , hyperpolarizing shift in window current (W1204R) [75] , and resistance to the decrease in channel activity upon high frequency depolarizations (D188V) [76] . However, loss-of-function mechanisms were described in part for the same mutations such as enhanced fast and slow inactivation (T875M, R1648H) [72, 73, 77] or a depolarizing shift of the steady-state activation curve (I1656M, R1657C) [78] which all reduce the amount of available sodium channels. Even a complete loss-offunction was described for two other GEFS + point mutations (V1353L, A1685V) [78] . Hence, loss-of-function mechanisms seem to predominate for GEFS + which is in agreement with the genetic findings in SMEI, as will be outlined below.
In contrast to the point mutations found in GEFS + families, most of the SMEI patients carry de novo nonsense mutations predicting truncated proteins without function [79] (Fig. 4B) . One SMEI point mutation was also shown to yield non-functional channels when expressed in human embryonic kidney cells [78] . The point mutations found for ICEGTC patients [66] have not been functionally examined so far. Interestingly, the sodium channel blocker lamotrigine, the only drug of this class which is in use in patients with idiopathic generalized epilepsies, deteriorates the clinical situation in SMEI patients; in particular, it can lead to an increased number of myoclonic seizures [80] , similar as in juvenile myoclonic epilepsy [81] . This observation confirms that SMEI is a loss-of-function sodium channel disorder caused by haploinsufficiency of SCN1A and from a genetic and clinical point of view -like ICEGTC -a severe allelic variant of GEFS + . The percentage of SMEI patients carrying sodium channel mutations is high but varies between 35 and 100% in different studies (references in Table 1 ).
As a loss-of-function of a voltage-gated sodium channel decreases membrane excitability, it seems paradoxical that such mutations can cause epilepsy. However, when acting predominantly on inhibitory neurons, this effect could well be responsible for the occurrence of hyperexcitability in neuronal circuits inducing epileptic seizures. Since SCN1A was not described to be expressed selectively in inhibitory neurons [82, 83] , a predominant effect of SCN1A mutations on inhibitory neurons is not evident and has to be demonstrated by further investigations.
GABA A Receptor Defects in GEFS + and Absence Epilepsy with Febrile Seizures
Confirming the hypothesis of an 'inhibited inhibition' (disinhibition) as a pathophysiological mechanism for GEFS + , subsequently mutations were found in the γ 2 -subunit of the GABA A receptor (gene GABRG2) in two GEFS + families. One of these families presented with a typical GEFS + phenotype (FS and FS + ; mutation K289M [84] ), the other one with a frequent combination of FS and absence seizures beside other epilepsy syndromes described for GEFS + (mutation R43Q [85] ). Only two more mutations were found in other samples up to now, one of those in a GEFS + family with one affected individual suffering from SMEI [86] . However, a bilineal inheritance with another yet unknown mutation in this patient was postulated so that it is questionable that GABRG2 can be considered as a SMEI gene. The other mutation occurred in a family in which all affected individuals were diagnosed as having childhood absence epilepsy (CAE) and FS [87] (Fig. 5) .
Functional studies of all GABRG2 mutations expressed in Xenopus oocytes or mammalian cell lines (γ 2 -subunits together with α 1 -and β 2 -or β 3 -subunits) revealed a more or less pronounced loss-of-function as a common pathogenic mechanism. The main gating defects described for the K289M mutation were a decrease in the macroscopic GABA-response and an increased rate of deactivation [84, 88] . For the R43Q mutation, results from two different groups were controversial, which may be explained by the use of different β-subunits for functional studies. A reduction of the benzodiazepine potentiation and increased rate of desensitization [85, 89] could not be confirmed [88] . Instead, a reduced macroscopic current was found by the other group [88] . The other two mutations presumably lead to a complete loss-of-function. Q351X did not yield measurable currents and confocal imaging with green-fluorescent protein (GFP)-tagged receptors revealed no surface expression of the truncated protein [86] . The second mutation alters a splice donor site predicting a non-functional protein as well [87] . Hence, all GABA A receptor mutations directly reduce the main mechanism for neuronal inhibition in the brain which can well explain the occurrence of epileptic seizures.
IDIOPATHIC GENERALIZED EPILEPSIES (IGE)
Clinical Picture
The four classical and most common subtypes of IGE are childhood and juvenile absence epilepsy (CAE, JAE), juvenile myoclonic epilepsy (JME), and epilepsy with Grand-Mal seizures on awakening (EGMA) [3] . Absence seizures in CAE manifest typically around the 6 th year of life. They are of short duration, usually about 10 s, and characteristically occur in clusters of up to 100 seizures a day. The EEG shows typical 3-4 Hz generalized spike and wave discharges. During adolescence, generalized tonicclonic seizures can develop. Absence seizures in JAE are principally similar. The age of manifestation is around puberty and the number of seizures is considerably lower, the typical clusters are usually not observed. Generalized tonic-clonic seizures occur more frequently than in CAE and some patients develop additional myoclonic seizures. Generalized myoclonic seizures with bilateral myoclonic jerks in particular of the upper extremities and without loss of consciousness are the hallmark of JME. The disease also manifests during puberty. Typically, seizures develop after awakening and can be provoked by sleep deprivation. Generalized tonic-clonic seizures occur in about 75% of patients. The EEG mostly shows generalized polyspikes. Epilepsy with Grand-Mal (generalized tonic-clonic) seizures on awakening develops in adolescence. Seizures usually occur in the first hours after the patients awake, independent of the day-time.
Genetics -General Aspects
In contrast to the syndromes discussed in the other parts of this article, IGE follows a complex genetic inheritance with the exception of rare large families presenting as an apparent dominant trait. While some of these families might really have a monogenic background, in most of them probably a major gene effect dominates the familial disease pattern which in addition depends on other modifying genes or on the genetic background. Different approaches have been used to identify IGE-causing genes. Linkage has been performed in single large families with many affected individuals, as well as in large samples of small, nuclear families. Furthermore, direct candidate gene approaches have been used. The results of these studies are summarized in Table 1 . Using all of these three approaches, the first mutations in ion channel encoding genes have been identified recently.
GABA A Receptor Defects
In addition to mutations in GABRG2 causing GEFS + or CAE with febrile seizures, a mutation was identified in GABRA1, the gene encoding the α 1 -subunit of the GABA A receptor, in a large family with pure JME [90] . As described above for all mutations in the γ 2 -subunit, the α 1 -subunit mutation, A322D (Fig. 5) , leads to a pronounced loss-offunction of the GABA A receptor. The main molecular Fig. (5) . Proposed transmembrane structure of the GABA A receptor with mutations causing GEFS + , CAE with febrile seizures or JME (references in Table 1 ) ($: splice site mutation). The main GABA A receptor in the brain is a pentamer (as the nAChR, compare Fig. 2) , composed of 2 α 1 -, 2 β 2 -and 1 γ 2 -subunits (inset lower right). Each subunit has 4 transmembrane segments (M1-M4), the M2 segments forming the ion pore.
mechanisms are a shift in the GABA sensitivity by two orders of magnitude and probably a reduced surface expression [90] . Thus, the spectrum of epilepsy syndromes which can be caused by direct GABAergic disinhibition extends from classical IGE phenotypes to febrile seizures.
Chloride Channel Defects
A second IGE gene identified, and the first one in which mutations are associated with all four classical IGE subtypes, is CLCN2 encoding the voltage-gated Cl -channel ClC-2. A search for mutations in this gene was initiated after a genome scan in nuclear IGE families had shown significant linkage to chromosome 3q26 at which CLCN2 is located [91] . ClC-2 has been proposed to play an important role in neuronal Cl -homeostasis [92, 93] , which is crucial for GABAergic inhibition, and therefore CLCN2 was chosen as an excellent candidate gene. GABA A receptors are synaptic ion channels which open in response to GABA to induce a passive flow of Cl -ions. Their potential to inhibit the postsynaptic neuron therefore critically depends on the transmembrane Cl -gradient. Since an inflow of Cl -ions hyperpolarizes the cell membrane whereas an outflow leads to a depolarization, [Cl - ] i has to be kept on a low level to enable and maintain an inhibitory GABA response. ClC-2 is a voltage-gated Cl -channel with strong expression in brain [94, 95] . The channel is activated upon membrane hyperpolarization at potentials more negative than the Cl -equilibrium potential (E Cl ) and thus constitutes an exclusive efflux pathway for Cl -ions at an increased [Cl -] i , well suited to maintain an inhibitory GABA response [92, 96] .
Three mutations within CLCN2 were described in three unrelated families affected with JME or EGMA, CAE or EGMA, or JAE, respectively. The mutations predict (i) a premature stop codon (M200fsX231), (ii) an atypical splicing (del74-117), and (iii) a single amino acid substitution (G715E). Functional characterization of all three mutations in a mammalian cell line (tsA201) revealed distinct explanations for their pathogenic phenotypes. M200fsX231 and Fig. (6) . (A) Proposed transmembrane structure of the ClC-2 Cl -channel derived from the crystal structure of a bacterial Cl -channel [161] with two mutations (M200fsX231, G715E) found in two independent IGE families and a splice variant lacking exon 3 (del74-117) which is expressed at higher levels due to an intronic deletion identified in a third IGE family [96] . (B) Cl -currents recorded with the whole-cell patch clamp technique from transfected human embryonic kidney cells (tsA201). M200fsX231 and del74-117 cause a complete loss-of-function, whereas G715E shows Cl -currents similar to the wild type channel but with an altered voltage-and Cl --dependent gating as shown in (C). (C) Midpoint of voltage-dependent activation (V 0.5 ) plotted against the internal Cl -concentration. In the range of physiological Cl -concentrations the activation curve shifted in the depolarizing direction for G715E compared to the wild type (modified after [96] ).
del74-117 caused a dominant negative loss-of-function of ClC-2 channels which should decrease the transmembrane Cl -gradient and lead to a reduced inhibitory GABA response. G715E lead to a depolarizing shift of voltage-and Cl --dependent activation of the channel, i.e. a gain-of-function mechanism, inducing membrane depolarization and hyperexcitability due to an increased Cl -outflow. Hence, both mechanisms finally should induce a hyperexcitability of the postsynaptic membrane in GABAergic synapses which can explain the occurrence of epileptic seizures [96] . These results underline an important role of ClC-2 in GABAergic inhibition and confirm the crucial role of GABAergic inhibition in the pathophysiology of idiopathic epilepsies which has already been discussed in previous paragraphs of this article.
Furthermore, two recent reports point to similar molecular pathophysiological aspects in mesial temporal lobe epilepsy, the most frequent form of acquired partial epilepsies. For both (i) human epileptic tissue derived from patients undergoing epilepsy surgery due to hippocampal sclerosis and (ii) a bihippocampal animal model with induction of an epileptic mirror focus, it could be shown that epileptic activity goes along with a paradoxical GABAergic excitation and shift in the chloride equilibrium potential [97, 98] . This might be explained by a secondary change of chloride transport proteins or channels as ClC-2.
Calcium Channel Mutations
Finally, direct candidate gene approaches also lead to the discovery of mutations in ion channel encoding genes in IGE patients. One mutation was discovered in a patient with JME in the gene CACNB4, encoding the β 4 -subunit of the high voltage-gated L-type Ca 2+ channel, predicting a premature stop codon (R482X), another mutation in a father and son affected with JAE (C104F). The latter mutation was also detected in another family with episodic ataxia type II (EA-2). Functional studies revealed small differences in channel gating for R482X and both mutations lead to little but significant reduction in current size [99] . Similarly, a mutation was found in CACNA1A, predicting a R1820X truncation of the α 1 -subunit of the same channel complex, in a patient suffering from IGE, episodic and progressive ataxia and cognitive impairment. Functional studies as well showed impaired channel function [100] . Naturally occurring mutations in different subunits of the same channel complex are well known to cause epilepsy with generalized spike and wave discharges in several mouse models [101] .
In a chinese study with CAE patients, 20 different mutations were recently discovered in CACNA1H, the gene encoding the α 1 -subunit of a low-voltage-activated T-type Ca 2+ channel [102] . The first functional studies of five of these mutations indicate a gain-of-function for some of them [103] . The results are very interesting with regard to the pathophysiology of absence seizures. Thalamic neurons in thalamo-cortical loops are thought to generate the rhythmic activity underlying generalized spike and wave discharges and T-type Ca 2+ channels play a crucial role for the depolarizing phase of the rhythmic activity in these thalamic neurons [104] . Ethusuximide, an efficient drug in the treatment of absence seizures, blocks T-type Ca 2+ channels. A knock-out mouse of another T-type Ca 2+ channel α 1 -subunit (gene CACNA1G) is resistant to the induction of spike and wave discharges [105] . Thus, a gain-of-function is the expected pathomechanism such as already observed for some of the mutations in CACNA1H associated with CAE [103] .
IMPLICATIONS FOR THERAPY
The discovery of genetic defects and in particular the electrophysiological characterization of mutant ion channels elucidates pathophysiological concepts of hyperexcitability in the brain. This knowledge enables new therapeutic strategies by antagonizing the epilepsy-causing mechanisms. In particular, the defective proteins can be used as new pharmacological targets. In the cause of identifying the genetic defect of BFNC, a completely novel approach of anticonvulsive treatment emerged from identifying retigabine as an activator of M-currents conducted by KCNQ2 and KCNQ3 K + channels. Retigabine shifts the voltage dependence of activation of these channels by about 20 mV in the hyperpolarizing direction so that they are active at the resting membrane potential [106] . This stabilizes the cell membrane via hyperpolarization towards the K + equilibrium potential, a very potent anticonvulsive mechanism, which is not in clinical use up to now.
CONCLUDING REMARKS
In summary, a tremendous progress has been made in recent years to understand the genetic and pathophysiologic basis of idiopathic epilepsies. After the discovery of the first gene defects in rare monogenic syndromes, we now get the first positive and encouraging results also for the common epilepsy syndromes. Both focal and generalized idiopathic epilepsies are almost exclusively caused by ion channel mutations ( Table 1) . This emerges as a plausible pathophysiological concept, since defects of ion transport by mutations in channel genes usually only affect the excitability of neurons and neuronal networks but do not induce structural lesions. GABAergic inhibition plays a central role in the pathogenesis of idiopathic generalized epilepsies and there are parallels to pathophysiolgical concepts of acquired focal epilepsy syndromes. These results strongly enhance our knowledge about the etiology and pathogenesis of the epilepsies and hopefully will contribute to develop new therapies. One such novel anticonvulsive mechanism, the activation of a neuronal potassium conductance, could already be elucidated on the molecular level by the identification of a new epilepsy gene.
